Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
J Cardiopulm Rehabil Prev. 2010 May-Jun;30(3):195-202. doi: 10.1097/HCR.0b013e3181c565e4.
To evaluate the relationship between the 6-minute walk distance (6MWD) and survival in a cohort of patients with severe end-stage chronic obstructive pulmonary disease (COPD) who received inpatient pulmonary rehabilitation (IPR) from 1995 to 2007.
We retrospectively analyzed 815 patients with severe end-stage COPD who received IPR. 6MWDs before and after IPR (pre-6MWD, post-6MWD) were compared to assess whether 6MWD was significantly changed after IPR. The Kaplan-Meier survival curves were constructed to show the relationship between survival and 6MWD. The age- and or comorbidities-adjusted Cox proportional hazard model was applied to assess association between the survival and the pre-6MWD, post-6MWD, or difference in 6MWD from the pre-6MWD to post-6MWD (Delta6MWD).
Baseline demographics demonstrated a median age 74.0 years, mostly women (60.1%), and white (89.9%) patients with significant comorbid diseases who were most recently hospitalized in acute care facilities (95.1%). IPR significantly increased the 6MWD (mean distance change: 86.4 m; 95% confidence interval [CI], 81.5-91.3 m). Pre-6MWD was not significantly associated with survival. However, post-6MWD was significantly associated with age- and comorbidity-adjusted survival (post-6MWD hazard ratio = 1.336; 95% CI, 1.232-1.449 [post-6MWD x m relative to post-6MWD 2x m]), and Delta6MWD was also significantly associated with age-, comorbidities-, and pre-6MWD-adjusted survival (Delta6MWD hazard ratio = 1.337; 95% CI, 1.227-1.457 [Delta6MWD x m relative to Delta6MWD 2x m]).
In patients with severe end-stage COPD, IPR significantly improved 6MWD, and the post-6MWD and Delta6MWD were positively associated with the length of survival.
评估 1995 年至 2007 年期间接受住院肺康复(IPR)治疗的严重终末期慢性阻塞性肺疾病(COPD)患者的 6 分钟步行距离(6MWD)与生存之间的关系。
我们回顾性分析了 815 名接受 IPR 的严重终末期 COPD 患者。比较 IPR 前后的 6MWD(预 6MWD、后 6MWD),以评估 IPR 后 6MWD 是否有显著变化。构建 Kaplan-Meier 生存曲线以显示生存与 6MWD 之间的关系。应用年龄和/或合并症调整的 Cox 比例风险模型评估生存与预 6MWD、后 6MWD 或预 6MWD 至后 6MWD 的 6MWD 差值(Delta6MWD)之间的关系。
基线人口统计学数据显示,中位年龄为 74.0 岁,大多数为女性(60.1%),白人(89.9%)患者,且合并症显著,最近在急症护理机构住院(95.1%)。IPR 显著增加了 6MWD(平均距离变化:86.4m;95%置信区间[CI],81.5-91.3m)。预 6MWD 与生存无显著相关性。然而,后 6MWD 与年龄和合并症调整后的生存显著相关(后 6MWD 风险比=1.336;95%CI,1.232-1.449[后 6MWD x m 相对于后 6MWD 2x m]),Delta6MWD 也与年龄、合并症和预 6MWD 调整后的生存显著相关(Delta6MWD 风险比=1.337;95%CI,1.227-1.457[Delta6MWD x m 相对于 Delta6MWD 2x m])。
在严重终末期 COPD 患者中,IPR 显著提高了 6MWD,后 6MWD 和 Delta6MWD 与生存时间呈正相关。